Patient-reported outcomes and apixaban therapy in older patients

Stefano Fumagalli; Giuseppe Di Pasquale; Simone Pupo; Giancarlo Agnelli; Niccolò Marchionni

doi:10.1016/j.ejim.2024.02.034

Related publications

Letter2025

Frailty, disability and patient-reported outcomes in apixaban users

Stefano Fumagalli, Giuseppe Di Pasquale, Giulio Molon, Giancarlo Agnelli, Niccolò Marchionni

Article2017

Reporting of Patient-Reported Outcomes in Randomized Trials

Melanie Calvert, Jane Blazeby, Douglas G. Altman, Dennis A. Revicki, David Moher, Michael Brundage

Article2013

Reporting of Patient-Reported Outcomes in Randomized Trials

Melanie Calvert, Jane Blazeby, Douglas G. Altman, Dennis A. Revicki, David Moher, Michael Brundage, for the CONSORT Group

Article2005

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial

Gerald G. Krueger, Richard G. Langley, A.Y. Finlay, Christopher Em Griffiths, J. Michael Woolley, Deepa Lalla, Angelika Jahreis

Article2019

PATIENT‐REPORTED OUTCOMES (PROs) IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB‐RITUXIMAB IN THE INNOVATE STUDY

Alessandra Tedeschi, Meletios A Dimopoulos, Judith Trotman, Ramón García‐Sánz, D. Blair Macdonald, Beatrice Mahé, Charles Herbaux, Leonard T. Heffner, Constantine S. Tam, Marzia Varettoni, M. Lia Palomba, J. Matous, Chaim Shustik, Efstathios Kastritis, Steven P. Treon, J. Li, Erik Poulsen, B. Hauns, Christian Buske, V. Leblond

Patient-reported outcomes and apixaban therapy in older patients

Discussion(0)

Related publications

Frailty, disability and patient-reported outcomes in apixaban users

Reporting of Patient-Reported Outcomes in Randomized Trials

Reporting of Patient-Reported Outcomes in Randomized Trials

Patient-reported outcomes of psoriasis improvement with etanercept therapy: results of a randomized phase III trial

PATIENT‐REPORTED OUTCOMES (PROs) IN WALDENSTRÖM MACROGLOBULINEMIA (WM) PATIENTS TREATED WITH IBRUTINIB‐RITUXIMAB IN THE INNOVATE STUDY